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Abstract 
Objectives: Induction of labour (IOL), or starting labour artificially, can be a lifesaving intervention for pregnant 
women and their babies, and rates are rising significantly globally. As rates increase, it becomes increasingly impor-
tant to fully evaluate all available data, especially that from low income settings where the potential benefits and 
harms are greater. The goal of this paper is to describe the datasets collected as part of the Induction with Foley OR 
Misoprostol (INFORM) Study, a randomised trial comparing two of the recommended methods of cervical ripening for 
labour induction, oral misoprostol and Foley catheter, in women being induced for hypertension in pregnancy, at two 
sites in India during 2013–15.
Data description: This dataset includes comprehensive data on 602 women who underwent IOL for hypertensive 
disorders in pregnancy. Women were randomly assigned to cervical ripening with oral misoprostol or a transcervical 
Foley catheter in two government hospitals in India. The main dataset has 367 variables including monitoring during 
the induction of labour, medications administered, timing and mode of delivery, measures of neonatal morbid-
ity and mortality, maternal mortality and morbidity, maternal satisfaction and health economic data. The dataset is 
anonymised and available on ReShare.
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Objectives
IOL rates are rising rapidly around the world, both in 
high and low income settings. High quality IOL studies 
from low income settings are rare, and most are under-
taken in high income settings. However, the findings 
of high income setting studies may not be applicable to 
resource constrained settings where the risks and ben-
efits of induction are far higher for patients, and adequate 
resources are often not available. Pre-eclampsia is one 
of the most prevalent causes of morbidity and mortal-
ity around the world. This dataset, which also includes 
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clinicians and policy makers investigating IOL, maternity 
care in high and low income settings and pre-eclampsia.
Low dose oral misoprostol and the Foley catheter are 
low cost cervical ripening methods recommended for use 
around the world including low income settings, where 
pre-eclampsia causes the most significant burden [1]. 
However few studies have directly compared them [2, 
3]. Few similar datasets of pre-eclamptic patients and 
IOL patients are currently available. The INFORM study 
was undertaken at two public hospitals in Nagpur, India, 
between December 2013 and June 2015. The aims of this 
randomised controlled trial were “to directly compare 
the efficacy, safety, acceptability and cost effectiveness 
of misoprostol and the Foley catheter in the induction of 
labour among women with gestational hypertension, in a 
low resource setting” [4, 5].
The study protocol [4], clinical results [5] and health 
economic analysis [6] have been published previously, 
but the dataset was not published at that time due to con-
cerns that some variables could potentially compromise 
patient and/or research staff confidentiality; these issues 
have now been resolved as described later in this paper.
Data description
Women included in this study were at least 18  years 
old, over 20 weeks’ gestation, with a live fetus and were 
scheduled to have an induced labour because of hyper-
tensive disorders of pregnancy. Women unable to give 
informed consent, those with a previous caesarean sec-
tion, multiple pregnancy, ruptured membranes, clinically 
diagnosed chorioamnionitis or a history of allergy to mis-
oprostol were not recruited [4].
After informed consent, 602 women were randomly 
assigned to labour induction with oral misoprostol 
(25 µg every 2 h for a maximum of 12 doses) or a tran-
scervical Foley catheter (size 18 F with 30  ml balloon). 
Randomisation schedules were computer-generated and 
administered using opaque sealed envelopes. Induc-
tion continued with artificial membrane rupture and 
oxytocin, administered through a micro-drip gravity 
infusion set [4].
Detailed information was collected on paper forms by 
research assistants at defined time points; immediately 
prior to IOL, at randomisation, every 2 h during the IOL 
process, at 24 h post-delivery and at discharge. Data were 
later double-entered into SPSS (IBM, Portsmouth, UK) 
by research staff in India and the US. The case report 
forms have been made publicly available along with a 
data dictionary and detailed description of methods (see 
Table 1).
Data on admission, induction and delivery includes 
basic demographic information, medical and obstetric 
history (current and previous), pre-eclampsia symptoms 
(severe nausea and vomiting, epigastric pain, headache, 
visual disturbance, chest pain or dyspnea), maternal and 
fetal observations and examination findings, detailed 
information on all medication administered, women’s 
expectations of pain and anxiety pre-IOL, side effects and 
complications of induction, mode of delivery and indica-
tion for delivery where relevant, complications and oper-
ative interventions. These data were used to calculate the 
number of vaginal births within specific timeframes (12, 
24 h) and induction to birth intervals.
Postnatal data includes information on morbidity, 
complications, mortality, women’s rating of accept-
ability (regarding the amount of time taken and anxi-
ety), whether women would recommend this method 
for future inductions, discharge dates and discharge 
medications.
Neonatal data include basic information such as birth 
outcome, birth weight, APGARs at 1, 5 and 10 min, age 
of first feed, gasp and heart rate over 100. Neonatal mor-
bidity including diagnosis, SCBU admission and length of 
stay, oxygen administration, ventilation, seizures and age 
at first seizure, discharge/death date and discharge medi-
cation. Upon discharge, babies admitted to the special 
care unit were assessed for encephalopathy and the com-
ponents of the original Sarnat score recorded [4].
Table 1 Overview of data files/data sets
Label Name of data file/data set File types
(file extension)
Data repository and identifier (DOI or accession number)
Data file 1 INFORM database_CSV_160121 CSV data file (.csv) UK Data Service ReShare http:// doi. org/ 10. 5255/ UKDA- SN- 
854663 [7]
Data file 2 INFORM_database_Excel_060121 MS Excel file (.xlsx) UK Data Service ReShare http:// doi. org/ 10. 5255/ UKDA- SN- 
854663 [7]
Data file 3 INFORM_Data Dictionary_160121_sharing version MS Excel file (.xlsx) UK Data Service ReShare http:// doi. org/ 10. 5255/ UKDA- SN- 
854663 [7]
Data file 4 Detailed_methods_INFORM_16NOV20.docx MS Word file (.docx) UK Data Service ReShare http:// doi. org/ 10. 5255/ UKDA- SN- 
854663 [7]
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Full details of the outcomes collected are included in 
the downloadable data dictionary and case report forms 
(see Table 1).
Due to concerns that including explicit dates (par-
ticularly date of delivery) could compromise anonym-
ity, all dates have been replaced by number of days from 
a seed date prior to the start of this study; the identity 
of the seed date can be obtained on request, where 
appropriate.
Limitations
This was a pragmatic study, based in busy Government 
Hospitals, where clinical decisions are typically made 
quickly, often without the full diagnostic work-ups and 
investigations required to differentiate between sub-
groups of hypertension in pregnancy (i.e. separation 
into proteinuric or non-proteinuric hypertension, or 
HELLP syndrome). Urinalysis was often not available, 
therefore making these results more generalizable to 
the whole population, but less focused on the treatment 
of hypertensive disorders specifically. Further investiga-
tions such as blood tests were not recorded.
This was an un-blinded study, due to ethical and practi-
cal concerns associated with undertaking unnecessary or 
sham Foley catheterisation. Whilst this risks bias, neither 
treatment was commonly used in the recruiting hospitals 
prior to this study and therefore clinician’s pre-existing 
views about treatment efficacy were unlikely to affect 
clinical decisions on these induction methods.
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